Synthetic biology company that creates new proteins for health and sustainable manufacturing applications
Biomatter has raised €6.5M across 1 funding round from 5 investors, most recently a Seed round in Aug 2024. Based in Vilnius, Lithuania; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-08-06 | Seed | €6.5M |
| Business Angels,Inventure VC,Metaplanet,Practica Capital,UVC Partners |
| View deal → |
